Clinical Investigations of Dibromodulcitol in the Treatment of Malignant Diseases
DBD (1,6,Dibromo-1,6,Dideoxydulcitol) is a cytostatic sugar-alcohol derivative. It was synthetized by Horvath and Institoris in the Chinoin Pharmaceutical Factory in Hungary. DBD is a stereoisomeric variant of another Hungarian drug, Dibromomannitol or Myelobromol. The position of the hydroxyl-groups is the difference between the two compounds.
KeywordsPolycythemia Vera Squamous Cell Cancer Myeloproliferative Disease Ical Type Haematological Side Effect
Unable to display preview. Download preview PDF.